Compare with another brand → · RSS
Houston Enzymes
Houston Enzymes has 15 on-market SKUs in the DSLD, first entered 2014-05-23. 80.0% of its products declare at least one proprietary blend, and 57.1% of all its all-time SKUs are now off-market.
15
on-market SKUs
80.0%
with a blend
0.0%
gummies
57.1%
off-market churn
Report card
- Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): —
- % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 0.0%
- Average excipient count per product: 3.9
- First entry: 2014-05-23 · Latest entry: 2025-02-23
Compared with the median brand
Context for the numbers above: the same measures for the median of the 1,430 brands with at least 10 on-market products. A difference from the median is a description, not a grade; a specialty brand can sit far from the median for good reasons.
| Measure | Houston Enzymes | Median brand |
|---|---|---|
| Products with a proprietary blend | 80% | 26.7% |
| Products in an exact Formula Twins cluster | 0% | 10% |
| Products declaring a dose above an adult UL | 0% | 0% |
| Products listing a synthetic FD&C dye | 0% | 0% |
| Products listing titanium dioxide | 0% | 0% |
| Gummies | 0% | 0% |
| Products with a certification statement | 0% | 0% |
| Average excipients per product | 3.9 | 4.5 |
| All-time SKUs now off-market | 57.1% | 15.4% |
What it sells
- Capsule: 11 (73.3%)
- Tablet or Pill: 3 (20.0%)
- Powder: 1 (6.7%)
Compounds declared most often
- Probiotics (Total CFU): 2 products
Products (35)
| Product | Form | Status |
|---|---|---|
| AFP-Peptizyde with DPP IV Activity | Capsule | off-market |
| Lypazyme | Capsule | off-market |
| Lypazyme | Capsule | off-market |
| No-Fenol | Capsule | off-market |
| No-Fenol | Capsule | off-market |
| TriEnza | Capsule | off-market |
| TriEnza | Capsule | off-market |
| TriEnza | Capsule | off-market |
| TriEnza | Capsule | off-market |
| TriEnza Chewable | Tablet or Pill | off-market |
| TriEnza Chewable with DPP IV Activity | Tablet or Pill | off-market |
| TriEnza Powder | Powder | off-market |
| TriEnza Powder | Powder | off-market |
| TriEnza Powder with DPP IV Activity | Powder | off-market |
| TriEnza with DPP IV Activity | Capsule | off-market |
| TriEnza with DPP IV Activity | Capsule | off-market |
| ZyCarb | Capsule | off-market |
| Zyme Prime | Capsule | off-market |
| Zyme Prime | Capsule | off-market |
| Zyme Prime | Capsule | off-market |
| AFP-Peptizyde with DPP IV Activity | Capsule | on-market |
| AFP-Peptizyde with DPP IV Activity | Capsule | on-market |
| Biomuve | Capsule | on-market |
| Biomuve | Capsule | on-market |
| Lypazyme | Capsule | on-market |
| No-Fenol | Capsule | on-market |
| No-Fenol Chewable | Tablet or Pill | on-market |
| TriEnza | Capsule | on-market |
| TriEnza | Capsule | on-market |
| TriEnza Chewable | Tablet or Pill | on-market |
| TriEnza Powder | Powder | on-market |
| ZyCarb | Capsule | on-market |
| ZyCarb | Capsule | on-market |
| Zyme Prime | Capsule | on-market |
| Zyme Prime Chewable Pomegranate Raspberry | Tablet or Pill | on-market |